1-ethyl-3-(3-dimethylaminoethyl)carbodiimide has been researched along with arginine vasopressin in 1 studies
Studies (1-ethyl-3-(3-dimethylaminoethyl)carbodiimide) | Trials (1-ethyl-3-(3-dimethylaminoethyl)carbodiimide) | Recent Studies (post-2010) (1-ethyl-3-(3-dimethylaminoethyl)carbodiimide) | Studies (arginine vasopressin) | Trials (arginine vasopressin) | Recent Studies (post-2010) (arginine vasopressin) |
---|---|---|---|---|---|
68 | 0 | 10 | 12,278 | 422 | 1,212 |
Protein | Taxonomy | 1-ethyl-3-(3-dimethylaminoethyl)carbodiimide (IC50) | arginine vasopressin (IC50) |
---|---|---|---|
Vasopressin V2 receptor | Homo sapiens (human) | 0.242 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davies, AR; Wheatley, M | 1 |
1 other study(ies) available for 1-ethyl-3-(3-dimethylaminoethyl)carbodiimide and arginine vasopressin
Article | Year |
---|---|
The importance of acidic amino acid residues in the binding of ligands to the V1a vasopressin receptor.
Topics: Animals; Arginine Vasopressin; Binding Sites; Carbodiimides; Cell Membrane; Dicyclohexylcarbodiimide; Kinetics; Ligands; Liver; Protein Binding; Rats; Receptors, Vasopressin | 1995 |